vTv Therapeutics Inc.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Sep 2025 | Jun 2025 | Mar 2025 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-13.1M | $24.1M | $-8.7M | $-6.0M | $-5.1M | $-4.8M | $-5.2M | $-4.9M |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | — | $1.0K | — | — | $9.0K | — | — | $22.0K |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | — | $1.4M | — | — | $813.0K | — | — | $220.0K |
| Net Cash from Operating Activities | $-11.4M | $9.2M | $-5.2M | $-5.1M | $-5.7M | $-6.4M | $-6.7M | $-7.3M |
| Investing Activities | ||||||||
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | — | — | — | — | — | — | — |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | — | — | — | — | $0 | — | — | $50.1M |
| Net Change in Cash | — | $9.2M | — | — | $-5.7M | — | — | $42.8M |
| Free Cash Flow | — | — | — | — | — | — | — | — |